Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-16-007316
Filing Date
2016-08-19
Accepted
2016-08-19 16:13:38
Documents
47
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q globalfuture_10q-063016.htm 10-Q 436120
2 CERTIFICATION globalfuture_10q-ex3101.htm EX-31.1 11351
3 CERTIFICATION globalfuture_10q-ex3102.htm EX-31.2 11250
4 CERTIFICATION globalfuture_10q-ex3201.htm EX-32.1 3742
5 CERTIFICATION globalfuture_10q-ex3202.htm EX-32.2 3761
6 GRAPHIC image_001.jpg GRAPHIC 3187
  Complete submission text file 0001019687-16-007316.txt   1768206

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ftcy-20160630.xml EX-101.INS 218315
8 XBRL SCHEMA FILE ftcy-20160630.xsd EX-101.SCH 20838
9 XBRL CALCULATION FILE ftcy-20160630_cal.xml EX-101.CAL 45466
10 XBRL DEFINITION FILE ftcy-20160630_def.xml EX-101.DEF 30920
11 XBRL LABEL FILE ftcy-20160630_lab.xml EX-101.LAB 152093
12 XBRL PRESENTATION FILE ftcy-20160630_pre.xml EX-101.PRE 105348
Mailing Address 2 PARK PLAZA SUITE 4 IRVINE CA 92614
Business Address 2 PARK PLAZA SUITE 4 IRVINE CA 92614 (949) 769-3550
Global Future City Holding Inc. (Filer) CIK: 0001164964 (see all company filings)

EIN.: 980360989 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-33519 | Film No.: 161843316
SIC: 2834 Pharmaceutical Preparations